Avasant partnered with a global health innovation fund to accelerate the review and assessment of large-scale research initiatives aimed at addressing infectious disease threats. The organization sought to modernize its business processes and reduce the time-to-decision for critical funding allocations.
The client’s existing process for reviewing scientific research submissions was complex and time-consuming—often taking several months across multiple stages. With hundreds of applications received each cycle, manual assessments created bottlenecks, delayed outcomes, and introduced the risk of inconsistent evaluations.
Avasant deployed a custom AI solution to streamline submission intake, assess evaluation criteria, and deliver insights that supported faster and more accurate decision-making. The solution was designed to scale across multiple research domains, from vaccine development to supply chain innovation.
Reduced evaluation timelines by 45%
Achieved up to 60% in effort reduction cross evaluation and shortlisting areas
Login to get free content each month and build your personal library at Avasant.com